Altimmune, Inc. (ALT) Capital expenditures 2015–2025
Altimmune, Inc. (ALT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$11,000FY2025 · since FY2015: $86,507 → $11,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11,000 | — |
| FY2023 | $47,000 | -62.7% |
| FY2022 | $126,000 | -99.0% |
| FY2021 | $12.1M | +5841.0% |
| FY2020 | $203,957 | +16522.4% |
| FY2019 | $1,227 | -99.9% |
| FY2018 | $975,407 | +767.5% |
| FY2017 | $112,441 | -10.0% |
| FY2016 | $124,955 | +44.4% |
| FY2015 | $86,507 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice